SOPHARMA AD - Notification for a signed annex to the Contract for transformation through merger - Medica AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 12 / 2017

Date of issue: 2017-03-21

Short name of the issuer

SOPHARMA AD

Subject

Notification for a signed annex to the Contract for transformation through merger - Medica AD

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

Sopharma AD (the “Company”) notifies that on 20 March 2017 Sopharma AD, Sofia, UIC 831902088 and Medica AD, Sofia, UIC 000000993 signed an annex to the Contract for transformation through merger reflecting the comments by the FSC. All documents will be filed with the FSC for approval pursuant to art. 124, par. 1 of the Public Offering of Securities Act (POSA) after an independent certified evaluator prepares a report. As a result of the merger, all shareholders of the transferring company Medica AD, with the exception of the receiving company Sopharma AD, which is also a shareholder of the transferring company, will receive shares of Sopharma AD and become shareholders of it. Against one share of Medica AD each shareholder pursuant to art. 261b, app. 1 of the CA shall receive 0.8831 treasury shares of the capital of Sopharma AD. All other conditions concerning the merger procedure are included in the Contract.

Annexes

File Description

Notification_Medica_annex_21032017.doc Notification for a signed annex to the Contract for transformation through merger - Medica AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-03-21 Ognian Donev Executive director